ReviewCancers2022

Updated Neoadjuvant Treatment Landscape for Early Triple Negative Breast Cancer: Immunotherapy, Potential Predictive Biomarkers, and Novel Agents.

Giovanna Garufi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.